Atlas Trials

Efficacy and Safety of 0.01%, 0.03%, and 0.05% Atropine Eye Drops in Reducing Myopia Progression

Clinical trial NCT07626892 · COMPLETED

Trial details

NCT number
NCT07626892
Sponsor
Khyber Medical College, Peshawar
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Myopia ProgressionAtropine
Start date
2024-06-03
Primary completion
2026-05-22
Enrollment
95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.